RAF1 and infection: To confirm that GW5074 can inhibit DENV NS5 nuclear localisation in infected cells, Vero cells were treated with or without GW5074 (or the NS5 targeting agent 4-HPR as a control) 2 h prior to infection with DENV-2 (MOI 4).